HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36 | 0.0% | 31,185 | 0.0% | 0.02% | 0.0% |
Q2 2023 | $36 | -83.9% | 31,185 | -78.9% | 0.02% | -81.8% |
Q1 2023 | $223 | -39.7% | 147,862 | 0.0% | 0.13% | -37.4% |
Q4 2022 | $370 | -99.8% | 147,862 | +179.7% | 0.21% | +48.6% |
Q3 2022 | $223,000 | +51.7% | 52,862 | 0.0% | 0.14% | +61.4% |
Q2 2022 | $147,000 | -51.8% | 52,862 | -0.9% | 0.09% | -44.7% |
Q1 2022 | $305,000 | -37.4% | 53,362 | 0.0% | 0.16% | -35.1% |
Q4 2021 | $487,000 | -14.4% | 53,362 | +0.2% | 0.24% | -16.7% |
Q3 2021 | $569,000 | -36.0% | 53,262 | -7.0% | 0.29% | -30.3% |
Q2 2021 | $889,000 | +247.3% | 57,261 | +262.4% | 0.42% | +257.6% |
Q1 2021 | $256,000 | +6.2% | 15,799 | +38.6% | 0.12% | -9.2% |
Q4 2020 | $241,000 | +62.8% | 11,400 | +14.0% | 0.13% | +21.5% |
Q3 2020 | $148,000 | +0.7% | 10,000 | 0.0% | 0.11% | +2.9% |
Q2 2020 | $147,000 | +25.6% | 10,000 | 0.0% | 0.10% | -11.1% |
Q1 2020 | $117,000 | – | 10,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |